Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteer, Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07083089
What this trial is testing

Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)

Who this might be right for
Mild Cognitive Impairment (MCI) AmnesticParkinson Disease (PD)Healthy Participants
Cilcare SAS 309
Early research (Phase 1)Study completedNCT01005862
What this trial is testing

Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers

Who this might be right for
Alzheimer's Disease
Pfizer 17
Early research (Phase 1)UnknownNCT06373094
What this trial is testing

A Single Dose Escalation Study of HHT201 in Healthy Subjects

Who this might be right for
Alzheimer Disease
Shanghai Synergy Pharmaceutical Sciences Co., Ltd. 64
Early research (Phase 1)Study completedNCT00519298
What this trial is testing

Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects

Who this might be right for
HealthyAdult
Wyeth is now a wholly owned subsidiary of Pfizer 25
Not applicableEnrolling By InvitationNCT00585572
What this trial is testing

Wisconsin Brain Donor Program

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
University of Wisconsin, Madison 9,999
Early research (Phase 1)Study completedNCT00687141
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects

Who this might be right for
Alzheimer's Disease
AstraZeneca 112
Testing effectiveness (Phase 2)Study completedNCT00480701
What this trial is testing

Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease

Who this might be right for
Alzheimer DiseaseParkinson Disease
Institute for Neurodegenerative Disorders 26
Early research (Phase 1)WithdrawnNCT00884533
What this trial is testing

QTc Study of Rosi XR in Healthy Volunteers

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline
Early research (Phase 1)Looking for participantsNCT07169630
What this trial is testing

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

Who this might be right for
Alzheimer s DiseaseMild Cognitive ImpairmentHealthy
National Institute of Mental Health (NIMH) 90
Early research (Phase 1)Study completedNCT00499642
What this trial is testing

Study Evaluating the Effect of Lecozotan SR on the QTc Interval

Who this might be right for
Alzheimer DiseaseHealthy
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableStudy completedNCT04733989
What this trial is testing

A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease, Early OnsetMild Cognitive Impairment+3 more
GAP Innovations, PBC 1,002
Early research (Phase 1)Study completedNCT01294540
What this trial is testing

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly Cohort

Who this might be right for
Alzheimer's Disease
Eisai Inc. 73
Not applicableStudy completedNCT02973971
What this trial is testing

ADDIA Chronobiological Study

Who this might be right for
Alzheimer Disease
Amoneta Diagnostics SAS 24
Early research (Phase 1)Study completedNCT01565330
What this trial is testing

Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 20
Early research (Phase 1)Study completedNCT00979316
What this trial is testing

Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects

Who this might be right for
Alzheimer Disease
Bristol-Myers Squibb 62
Early research (Phase 1)Study completedNCT03418688
What this trial is testing

A Multiple Ascending Dose Study of COR388

Who this might be right for
Alzheimer Disease
Cortexyme Inc. 33
Early research (Phase 1)Study completedNCT01747213
What this trial is testing

Bisnorcymserine in Healthy Adult Volunteers

Who this might be right for
Healthy Volunteers
National Institute on Aging (NIA) 75
Early research (Phase 1)UnknownNCT06127368
What this trial is testing

Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics From Single Dose of Intramuscular (IM) and Subcutaneous (SC) Donepezil (GB-5001) Injections Versus Donepezil Oral Tablet (Aricept®) in Healthy Male Volunteers

Who this might be right for
Alzheimer Disease
G2GBio, Inc. 56
Early research (Phase 1)Study completedNCT02323334
What this trial is testing

LY3202626 in Healthy Participants and Participants With Alzheimer's Disease

Who this might be right for
Healthy VolunteersAlzheimer Disease
Eli Lilly and Company 94
Early research (Phase 1)Study completedNCT00988624
What this trial is testing

A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)

Who this might be right for
Alzheimer's DiseaseHuntington Disease
Pfizer 20
Next Page